3 completed, 2 withdrawn, 1 terminated. 3 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Stage 0 Cervical Cancer: new trials by email Literature Review of Stage 0 Cervical Cancer trials Research Report on Stage 0 Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening Cervical Papanicolaou Test, Cytology Specimen Collection Procedure, Questionnaire Administration - Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma | Not applicable | Completed | University of Washington | 1335 | 2012-03-01 | 2020-07-31 |
| Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Management of Therapy Complications, Quality-of-Life Assessment - Lymphedema, Stage 0 Cervical Cancer | Phase 3 | Terminated | Gynecologic Oncology Group | 2 | 2007-12-01 | 2021-06-23 |
| Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Celecoxib, Laboratory Biomarker Analysis, Placebo - Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | Phase 2 | Completed | Gynecologic Oncology Group | 130 | 2005-06-01 | 2017-09-15 |
| Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer Cervical Papanicolaou Test, Conization, Laboratory Biomarker Analysis - Precancerous Condition, Stage 0 Cervical Cancer | Not applicable | Completed | Gynecologic Oncology Group | 684 | 1998-09-01 | 2015-05-29 |
| Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer colposcopy, cervical Papanicolaou test, screening method - Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2 | Not applicable | Withdrawn | Northwestern University | 2012-06-11 | ||
| S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix celecoxib, anti-cytokine therapy, antiangiogenesis therapy - Stage 0 Cervical Cancer, High-grade Squamous Intraepithelial Lesion | Phase 2 | Withdrawn | SWOG Cancer Research Network | 2013-11-08 |
Uterine Cervical Dysplasia (6) · Uterine Cervical Neoplasms (4) · Vulvar Neoplasms (2) · Atypical Squamous Cells of the Cervix (1) · Lymphedema (1) · Papillomavirus Infections (1) · Precancerous Conditions (1) · Squamous Intraepithelial Lesions (1) · Vaginal Neoplasms (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Genital Diseases (6) · Genital Diseases, Female (6) · Neoplasms (6) · Urogenital Diseases (6) · Uterine Cervical Diseases (6) · Uterine Diseases (6) · Precancerous Conditions (5) · Genital Neoplasms, Female (4) · Neoplasms by Site (4) · Urogenital Neoplasms (4) · Uterine Neoplasms (4) · Morphological and Microscopic Findings (2) · Pathological Conditions, Signs and Symptoms (2)
Vaginal Smears (3) · Celecoxib (2) · High-Throughput Screening Assays (2) · Biological Therapy (1) · Chemoprevention (1) · Colposcopy (1) · Conization (1)
Gynecologic Oncology Group (3) · Northwestern University (1) · SWOG Cancer Research Network (1) · University of Washington (1)
United States (4)
Amy Halverson (1) · Janet Rader (1) · Levi Downs (1) · Nancy Kiviat (1) · Shu-Yuan Liao (1) · William R. Robinson, MD (1)
PMID 28285845, PMID 28332888, PMID 31264912
U10CA101165 (2), R01CA157469 (1), U10CA037429 (1)